Literature DB >> 21102541

A case of primary aldosteronism revealed after renal transplantation.

Ewout J Hoorn1, Dennis A Hesselink, Marcia M Kho, Joke I Roodnat, Willem Weimar, Jan L van Saase, Anton H van den Meiracker, Robert Zietse.   

Abstract

BACKGROUND: A 57-year-old woman was referred to a nephrology clinic because of chronic hypokalemia. She had a history of polycystic kidney disease, resistant hypertension, atrial fibrillation, type 2 diabetes, stroke, and end-stage renal disease, and had received a kidney transplant from a deceased donor at the age of 48 years. At presentation, the patient described symptoms of chronic fatigue and muscle aches, but she did not report pareses. Her medications included four antihypertensive agents, glucose-lowering drugs, immunosuppressants, digoxin, a coumarin derivative, and potassium chloride. INVESTIGATIONS: Full history, physical examination, laboratory testing of blood and urine, including aldosterone-torenin ratio, and a saline infusion test. DIAGNOSIS: Primary aldosteronism. MANAGEMENT: Treatment with spironolactone resulted in prompt control of hypertension and hypokalemia, allowing discontinuation of potassium chloride and reduction in antihypertensive medication.

Entities:  

Mesh:

Year:  2010        PMID: 21102541     DOI: 10.1038/nrneph.2010.158

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  39 in total

Review 1.  Hypertension in autosomal-dominant polycystic kidney disease: early occurrence and unique aspects.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2001-01       Impact factor: 10.121

2.  Primary aldosteronism detected after renal transplantation.

Authors:  C W Yang; Y S Kim; K H Yang; Y S Chang; Y S Yoon; B K Kim; B K Bang
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

3.  Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity.

Authors:  Gary L Schwartz; Stephen T Turner
Journal:  Clin Chem       Date:  2005-02       Impact factor: 8.327

4.  Medical management of aldosterone-producing adenomas.

Authors:  R P Ghose; P M Hall; E L Bravo
Journal:  Ann Intern Med       Date:  1999-07-20       Impact factor: 25.391

5.  Intrarenal hemodynamics in primary aldosteronism before and after treatment.

Authors:  Leonardo A Sechi; Alessandro Di Fabio; Massimo Bazzocchi; Alessandro Uzzau; Cristiana Catena
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

6.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

7.  Rare causes of adrenocortical hypertension.

Authors:  E G Biglieri
Journal:  Cardiology       Date:  1985       Impact factor: 1.869

Review 8.  Autosomal dominant polycystic kidney disease complicated by primary aldosteronism. Case report and review of the literature.

Authors:  F Gejyo; K Ishida; M Arakawa
Journal:  Am J Nephrol       Date:  1994       Impact factor: 3.754

Review 9.  Primary aldosteronism: an update on screening, diagnosis and treatment.

Authors:  Gian Paolo Rossi; Achille Cesare Pessina; Anthony M Heagerty
Journal:  J Hypertens       Date:  2008-04       Impact factor: 4.844

10.  Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium.

Authors:  Bruno Sontia; Augusto C I Montezano; Tamara Paravicini; Fatiha Tabet; Rhian M Touyz
Journal:  Hypertension       Date:  2008-02-11       Impact factor: 10.190

View more
  5 in total

1.  Kidney dysfunction following adrenalectomy in autosomal dominant polycystic kidney disease complicated with primary aldosteronism: A case report.

Authors:  Hiroyuki Hirai; Makoto Kanno; Tsuyoshi Watanabe; Hiroaki Satoh
Journal:  Exp Ther Med       Date:  2017-06-13       Impact factor: 2.447

Review 2.  Assessment and management of hypertension in transplant patients.

Authors:  Matthew R Weir; Ellen D Burgess; James E Cooper; Andrew Z Fenves; David Goldsmith; Dianne McKay; Anita Mehrotra; Mark M Mitsnefes; Domenic A Sica; Sandra J Taler
Journal:  J Am Soc Nephrol       Date:  2015-02-04       Impact factor: 10.121

3.  A young patient with a family history of hypertension.

Authors:  Aldo J Peixoto
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

Review 4.  New treatment paradigms for ADPKD: moving towards precision medicine.

Authors:  Matthew B Lanktree; Arlene B Chapman
Journal:  Nat Rev Nephrol       Date:  2017-10-09       Impact factor: 28.314

5.  A Real Saline Challenge: Diagnosing Primary Aldosteronism in the Setting of Chronic Kidney Disease.

Authors:  Sasan Mirfakhraee; Maria Rodriguez; Niloofar Ganji; Richard J Auchus; Oksana Hamidi
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.